Grant Support

Current Grant Support

Hyundai Hope on Wheels, "Anti-GD2 immunocytokine and NK cell infusions for neuroblastoma" (2016-2018). Capitini, Principal Investigator

NIH/Office of the Director (R24 OD021322), “CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS” (2016-2020). Capitini, Co-Investigator

Hyundai Hope on Wheels, “Anti-GD2 immunocytokine and NK cell infusions for neuroblastoma” (2016-2018).  Capitini, PI

NSF & EAGER Biomanufacturing, “A microscale testbed to assay and manufacture CAR T-cell immunotherapies” (2016-2018). Capitini, Co-PI

Novartis Pharmaceuticals, “Phase II study of redirected autologous T cells engineered to contain anti-CD19 attached to TCR and 4-1BB signaling domains in patients with chemotherapy resistant or refractory acute lymphoblastic leukemia” (2015-ongoing).  Capitini, PI

NIH/NCI (K08 CA174750), “Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy” (2014-2018). Capitini, PI

University of Wisconsin Fall Competition Award, “Enhancing the graft-versus-tumor effect against neuroblastoma” (2016-2017). Capitini, PI

Midwest Athletes Against Childhood Cancer, “Exploitation of the STAT1-BCL2 axis to dissect GVL from GVHD” (2015-2017). Capitini, PI

Novartis Pharmaceuticals, “Long term follow-up of patients exposed to lentiviral-based CD19 directed CART cell therapy” (2014-ongoing).  Capitini, PI

American Association for Cancer Research and the Children’s Hospital of Philadelphia, St. Baldrick’s – Stand Up 2 Cancer Foundations “Dream Team”, “Immunogenomics to create new therapies for high-risk childhood cancers” (2013-2017). Capitini, Young Investigator


Completed Grants

St. Baldrick's Foundation (Nicole Piscopo, Summer Fellowship), "Tagging CAR T cells for GD2+ cancers," (2016). Capitini, Mentor

Vilas (William F) Trust Estate, “Vilas Faculty Early Career Investigator award” (2015-2016). Capitini, PI

NIH/NCATS and University of Wisconsin Institute for Clinical and Translational Research (UL1 TR000427), “Infusing MEMs as protection from radiation injury and GVHD” (2014-2016). Capitini, ICTR Pilot Grant PI

American Society of Hematology (Tara Gavcovich, Hematology Opportunities for the Next Generation of Research Scientists), “ASH HONORS grant” (2015-2016). Capitini, Mentor

St Baldrick’s Foundation (Tara Gavcovich, Medical Student Fellowship), “Summer fellowship support” (2015). Capitini, Mentor

American Association of Immunologists (Myriam Bouchlaka, Post-doctoral Fellowship), “AAI careers in immunology fellowship” (2014-2015). Capitini, Mentor

Midwest Athletes Against Childhood Cancer (MACC) Fund, “Targeting the JAK1/STAT1 pathway to prevent GVHD and treat childhood leukemia” (2013-2015). Capitini, PI

Alex’s Lemonade Stand (Dennis Ea, Pediatric Oncology Student Training Program), “Inhibition of BCL2 in T cell ALL” (2014). Capitini, Mentor

St. Baldrick’s Foundation (Matthew Kutz, Summer Fellowship), “Monitoring of 19F-labeled NK cell trafficking for cancer immunotherapy using MRI” (2013). Capitini, PI

American Cancer Society and UW Carbone Cancer Center (Pilot Grant), "Monitoring of 19F-labeled NK cell trafficking for cancer immunotherapy using MRI" (2012-2013). Capitini, PI

Alex’s Lemonade Stand (Pediatric Oncology Student Training Program – Mallery Olsen), “Tracking of 19F labelled NK cells by MRI” (2012). Capitini, Mentor

Midwest Athletes Against Childhood Cancer (MACC) Fund, “Inhibiting STAT1 as a platform for GVHD resistance and preservation of GVL” (2011-2012). Capitini, PI

Hyundai Hope on Wheels, “Development of STAT1 inhibitors for pediatric leukemia and modulation of allogeneic bone marrow transplant” (2011-2012). Capitini, PI

Lisa’s Heart Kids’ Cancer Research Fund, “Treatment of pediatric solid tumors with natural killer cell therapy” (2009-2010). Capitini, PI